This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Elevated Plasma Clozapine Concentrations After Phenobarbital Discontinuation

Hsien-Yuan Lane, Kuan-Pin Su, Wen-Ho Chang, and Michael W. Jann

Published: March 15, 1998

Article Abstract

Sir: Clozapine, an atypical antipsychotic drug, is used mainly for treatment-resistant schizophrenia. Its metabolism is quite complex and involves a number of human cytochrome P450 enzymes and flavin-containing monooxygenases. Among them, cytochrome P450 1A2 (CYP1A2) appears to be the main enzyme responsible for the metabolism of clozapine. However, other isozymes, including CYP3A3/4, might also partially mediate clozapine’s disposition.

Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 59

Quick Links: Psychotic Disorders , Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Sublingual Dexmedetomidine for the Treatment of Acute Agitation in Adults With Schizophrenia or Schizoaffective Disorder: A Randomized Placebo-Controlled Trial

This RCT determined whether a single dose of sublingual dexmedetomidine reduced acute agitation associated with schizophrenia or...